PMID- 22952658 OWN - NLM STAT- MEDLINE DCOM- 20130219 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 8 DP - 2012 TI - AAV-mediated knock-down of HRC exacerbates transverse aorta constriction-induced heart failure. PG - e43282 LID - 10.1371/journal.pone.0043282 [doi] LID - e43282 AB - BACKGROUND: Histidine-rich calcium binding protein (HRC) is located in the lumen of sarcoplasmic reticulum (SR) that binds to both triadin (TRN) and SERCA affecting Ca(2+) cycling in the SR. Chronic overexpression of HRC that may disrupt intracellular Ca(2+) homeostasis is implicated in pathogenesis of cardiac hypertrophy. Ablation of HRC showed relatively normal phenotypes under basal condition, but exhibited a significantly increased susceptibility to isoproterenol-induced cardiac hypertrophy. In the present study, we characterized the functions of HRC related to Ca(2+) cycling and pathogenesis of cardiac hypertrophy using the in vitro siRNA- and the in vivo adeno-associated virus (AAV)-mediated HRC knock-down (KD) systems, respectively. METHODOLOGY/PRINCIPAL FINDINGS: AAV-mediated HRC-KD system was used with or without C57BL/6 mouse model of transverse aortic constriction-induced failing heart (TAC-FH) to examine whether HRC-KD could enhance cardiac function in failing heart (FH). Initially we expected that HRC-KD could elicit cardiac functional recovery in failing heart (FH), since predesigned siRNA-mediated HRC-KD enhanced Ca(2+) cycling and increased activities of RyR2 and SERCA2 without change in SR Ca(2+) load in neonatal rat ventricular cells (NRVCs) and HL-1 cells. However, AAV9-mediated HRC-KD in TAC-FH was associated with decreased fractional shortening and increased cardiac fibrosis compared with control. We found that phospho-RyR2, phospho-CaMKII, phospho-p38 MAPK, and phospho-PLB were significantly upregulated by HRC-KD in TAC-FH. A significantly increased level of cleaved caspase-3, a cardiac cell death marker was also found, consistent with the result of TUNEL assay. CONCLUSIONS/SIGNIFICANCE: Increased Ca(2+) leak and cytosolic Ca(2+) concentration due to a partial KD of HRC could enhance activity of CaMKII and phosphorylation of p38 MAPK, causing the mitochondrial death pathway observed in TAC-FH. Our results present evidence that down-regulation of HRC could deteriorate cardiac function in TAC-FH through perturbed SR-mediated Ca(2+) cycling. FAU - Park, Chang Sik AU - Park CS AD - College of Life Sciences and Systems Biology Research Center, Gwangju Institute of Science and Technology (GIST), Buk-gu, Gwangju, Republic of Korea. FAU - Cha, Hyeseon AU - Cha H FAU - Kwon, Eun Jeong AU - Kwon EJ FAU - Jeong, Dongtak AU - Jeong D FAU - Hajjar, Roger J AU - Hajjar RJ FAU - Kranias, Evangelia G AU - Kranias EG FAU - Cho, Chunghee AU - Cho C FAU - Park, Woo Jin AU - Park WJ FAU - Kim, Do Han AU - Kim DH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120828 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Calcium-Binding Proteins) RN - 0 (Carrier Proteins) RN - 0 (Muscle Proteins) RN - 0 (RNA, Small Interfering) RN - 0 (triadin) RN - 4QD397987E (Histidine) RN - EC 3.6.3.8 (Sarcoplasmic Reticulum Calcium-Transporting ATPases) RN - L628TT009W (Isoproterenol) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Aorta/*pathology MH - Calcium/*metabolism MH - Calcium-Binding Proteins/genetics/*metabolism MH - Cardiomegaly/pathology MH - Carrier Proteins/*metabolism MH - Constriction MH - Cytosol/metabolism MH - Dependovirus/*metabolism MH - Disease Models, Animal MH - Echocardiography/methods MH - *Gene Expression Regulation MH - Heart/physiology MH - Heart Failure/*genetics/physiopathology MH - Histidine/*chemistry MH - Homeostasis MH - Isoproterenol/pharmacology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Muscle Proteins/*metabolism MH - Phenotype MH - Phosphorylation MH - RNA, Small Interfering/metabolism MH - Sarcoplasmic Reticulum/*metabolism MH - Sarcoplasmic Reticulum Calcium-Transporting ATPases/*metabolism PMC - PMC3429470 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2012/09/07 06:00 MHDA- 2013/02/21 06:00 PMCR- 2012/08/28 CRDT- 2012/09/07 06:00 PHST- 2012/03/05 00:00 [received] PHST- 2012/07/23 00:00 [accepted] PHST- 2012/09/07 06:00 [entrez] PHST- 2012/09/07 06:00 [pubmed] PHST- 2013/02/21 06:00 [medline] PHST- 2012/08/28 00:00 [pmc-release] AID - PONE-D-12-06556 [pii] AID - 10.1371/journal.pone.0043282 [doi] PST - ppublish SO - PLoS One. 2012;7(8):e43282. doi: 10.1371/journal.pone.0043282. Epub 2012 Aug 28.